Veterinary Medicines Information website

GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens

Authorised
  • Infectious bronchitis virus, type 793/B, strain CR88121, Inactivated

Product identification

Medicine name:
GALLIVAC IB88 NEO effervescent tablet for suspension for nebulisation for chickens
Active substance:
  • Infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
Target species:
  • Chicken
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
    5.30
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 1 blister.
  • 1000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 10 blisters.
  • 2000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 1 blister.
  • 2000-dose tablets packaged in aluminium blister (10 tablets per blister), presented in a box of 10 blisters.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/056/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Updated on: 14/03/2026
Download